Baiyunshan (00874.HK) subsidiary obtains supplementary drug application approval.

The Zhitong Financial APP reported that Baiyunshan (00874.HK) announced that recently, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company"), a subsidiary of Baiyunshan, received a "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (hereinafter referred to as the "National Medical Administration").